Cannon Global Investment Management »

Century Therapeutics shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $111k 49k 2.26

More positions owned by Cannon Global Investment Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Norfolk Southern (NSC)
Terns Pharmaceuticals (TERN)
Sun Communities (SUI)
Madrigal Pharmaceuticals (MDGL)
Cheniere Energy Com New (LNG)
Qiagen Nv Ord Shares (QGEN)
Zoom Communications Cl A (ZM)
Cantor Equity Partners I Shs Cl A (CEPO)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Marvell Technology (MRVL)
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Renatus Tactical Acquis Shs Cl A (RTAC)
Ss&c Technologies Holding (SSNC)

View all positions for Cannon Global Investment Management

Top funds holding Century Therapeutics

RA Capital Management
TCG Crossover Management
Versant Venture Management
Deep Track Capital
Commodore Capital
VR Adviser
Point72 Asset Management
Vanguard Capital Management
Balyasny Asset Management
Millennium Management
Woodline Partners
Seven Fleet Capital Management
Trails Edge Capital Partners
DAFNA Capital Management
Two Sigma Investments

View all funds holding Century Therapeutics